PTU-021 Do all regenerative nodules become hepatocellular carcinoma? The outcome of 4 years MRI surveillance

IntroductionThere are few epidemiological data on the longitudinal follow-up of nodular lesions in cirrhotic patients.MethodsThe Royal Free Hospital database was searched for all reports of MRI scans of the liver in which the term “nodule” was used. 630 such scans were identified in 369 individual p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gut 2012-07, Vol.61 (Suppl 2), p.A192-A192
Hauptverfasser: Hogan, B, Trembling, P M, Tanwar, S, Yu, D, O'Beirne, J P, Rosenberg, W M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A192
container_issue Suppl 2
container_start_page A192
container_title Gut
container_volume 61
creator Hogan, B
Trembling, P M
Tanwar, S
Yu, D
O'Beirne, J P
Rosenberg, W M
description IntroductionThere are few epidemiological data on the longitudinal follow-up of nodular lesions in cirrhotic patients.MethodsThe Royal Free Hospital database was searched for all reports of MRI scans of the liver in which the term “nodule” was used. 630 such scans were identified in 369 individual patients between 1 January 2006 and 1 January 2011. Patients were then excluded if there was 1 year total follow-up with MRI and alpha-fetoprotein (AFP) surveillance.ResultsThe median age at first scan was 55 years (range 36–73) and the most common aetiologies of cirrhosis were hepatitis C (55%), hepatitis B (10%) and alcohol (25%) with 10% other. The median follow-up period was 22 months (12–56) and the median number of scans 4 (2–10). At baseline nodules were described as indeterminate in 48%, regenerative in 45% and dysplastic in 7%. The prevalence of HCC after 1, 2, 3 and 4 years of follow-up was 5 (17%), 9 (31%), 11 (38%) and 11 (38%) respectively, with the highest incidence occurring in the first 2 years of follow-up (82% of cases). The median size of nodule at baseline in those who developed HCC was 10 mm (5–18) and it was 9 mm (5–26) in those who did not. There was no association between the description of the nodule and the likelihood of developing HCC (five arising from indeterminate and 6 from regenerative nodules) and the two nodules initially described as dysplastic did not transform to tumour. AFP results were not informative.Conclusion31% of lesions described as arterialised nodules when first scanned developed into HCC within 2 years and initial radiological features consistent with “regenerative” nodules are not reassuring. Patients with discrete arterialised nodules should be enrolled in enhanced surveillance programmes.Competing interestsNone declared.
doi_str_mv 10.1136/gutjnl-2012-302514c.21
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2038746969</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2038746969</sourcerecordid><originalsourceid>FETCH-LOGICAL-b2561-59a8d8e85939a3119d9f723b4a4addb9107f0f0caeb171e9226558db83fcd9f13</originalsourceid><addsrcrecordid>eNqNkM1OGzEUha2KSgTKKyBLrE197fmxVxVKSUoFpaKhi24sj-cOTOqMgz2Dyq4bXpQnIWEQa1Zn851zpI-QQ-DHALL4fDP0y84zwUEwyUUOmTsW8IFMICsUk0KpHTLhHEqWl5neJXspLTnnSmmYkPXPxTXjAp7-P34N1HpPI95gh9H27T3SLtSDx0QrdGGF9BbXtg8OvR-8jdTZ6NourOwXurhFGob-hQoNzTZ7D2hjohdXZzQN8R5b723n8BP52Fif8OA198n17HQx_cbOL-dn05NzVom8AJZrq2qFKtdSWwmga92UQlaZzWxdVxp42fCGO4sVlIBaiCLPVV0p2bgNCnKfHI276xjuBky9WYYhdptLI7hUZVboQm-oYqRcDClFbMw6tisbHwxws7VrRrtma9e82jViO8_GYpt6_PfWsvGvKUpZ5ubH76mZ_5n9WnyfXZktDyNfrZbv_XgG5FeQYQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2038746969</pqid></control><display><type>article</type><title>PTU-021 Do all regenerative nodules become hepatocellular carcinoma? The outcome of 4 years MRI surveillance</title><source>BMJ Journals Online Archive</source><source>PubMed Central</source><creator>Hogan, B ; Trembling, P M ; Tanwar, S ; Yu, D ; O'Beirne, J P ; Rosenberg, W M</creator><creatorcontrib>Hogan, B ; Trembling, P M ; Tanwar, S ; Yu, D ; O'Beirne, J P ; Rosenberg, W M</creatorcontrib><description>IntroductionThere are few epidemiological data on the longitudinal follow-up of nodular lesions in cirrhotic patients.MethodsThe Royal Free Hospital database was searched for all reports of MRI scans of the liver in which the term “nodule” was used. 630 such scans were identified in 369 individual patients between 1 January 2006 and 1 January 2011. Patients were then excluded if there was &lt;1-year follow-up (45), if hepatocellular carcinoma (HCC) was identified on the initial scan (135), if an alternative diagnosis was made (129) or if no significant arterialised lesion was reported despite previous suspicion on ultrasound scanning (31). Retrospective analysis was, therefore, performed on 29 cirrhotic patients with a diagnosis of regenerative, indeterminate or dysplastic arterialised nodules at baseline and &gt;1 year total follow-up with MRI and alpha-fetoprotein (AFP) surveillance.ResultsThe median age at first scan was 55 years (range 36–73) and the most common aetiologies of cirrhosis were hepatitis C (55%), hepatitis B (10%) and alcohol (25%) with 10% other. The median follow-up period was 22 months (12–56) and the median number of scans 4 (2–10). At baseline nodules were described as indeterminate in 48%, regenerative in 45% and dysplastic in 7%. The prevalence of HCC after 1, 2, 3 and 4 years of follow-up was 5 (17%), 9 (31%), 11 (38%) and 11 (38%) respectively, with the highest incidence occurring in the first 2 years of follow-up (82% of cases). The median size of nodule at baseline in those who developed HCC was 10 mm (5–18) and it was 9 mm (5–26) in those who did not. There was no association between the description of the nodule and the likelihood of developing HCC (five arising from indeterminate and 6 from regenerative nodules) and the two nodules initially described as dysplastic did not transform to tumour. AFP results were not informative.Conclusion31% of lesions described as arterialised nodules when first scanned developed into HCC within 2 years and initial radiological features consistent with “regenerative” nodules are not reassuring. Patients with discrete arterialised nodules should be enrolled in enhanced surveillance programmes.Competing interestsNone declared.</description><identifier>ISSN: 0017-5749</identifier><identifier>EISSN: 1468-3288</identifier><identifier>DOI: 10.1136/gutjnl-2012-302514c.21</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Society of Gastroenterology</publisher><subject>Epidemiology ; Hepatitis ; Liver cancer ; Liver cirrhosis ; Surveillance</subject><ispartof>Gut, 2012-07, Vol.61 (Suppl 2), p.A192-A192</ispartof><rights>2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><rights>Copyright: 2012 © 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b2561-59a8d8e85939a3119d9f723b4a4addb9107f0f0caeb171e9226558db83fcd9f13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://gut.bmj.com/content/61/Suppl_2/A192.1.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://gut.bmj.com/content/61/Suppl_2/A192.1.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3196,23571,27924,27925,77600,77631</link.rule.ids></links><search><creatorcontrib>Hogan, B</creatorcontrib><creatorcontrib>Trembling, P M</creatorcontrib><creatorcontrib>Tanwar, S</creatorcontrib><creatorcontrib>Yu, D</creatorcontrib><creatorcontrib>O'Beirne, J P</creatorcontrib><creatorcontrib>Rosenberg, W M</creatorcontrib><title>PTU-021 Do all regenerative nodules become hepatocellular carcinoma? The outcome of 4 years MRI surveillance</title><title>Gut</title><addtitle>Gut</addtitle><description>IntroductionThere are few epidemiological data on the longitudinal follow-up of nodular lesions in cirrhotic patients.MethodsThe Royal Free Hospital database was searched for all reports of MRI scans of the liver in which the term “nodule” was used. 630 such scans were identified in 369 individual patients between 1 January 2006 and 1 January 2011. Patients were then excluded if there was &lt;1-year follow-up (45), if hepatocellular carcinoma (HCC) was identified on the initial scan (135), if an alternative diagnosis was made (129) or if no significant arterialised lesion was reported despite previous suspicion on ultrasound scanning (31). Retrospective analysis was, therefore, performed on 29 cirrhotic patients with a diagnosis of regenerative, indeterminate or dysplastic arterialised nodules at baseline and &gt;1 year total follow-up with MRI and alpha-fetoprotein (AFP) surveillance.ResultsThe median age at first scan was 55 years (range 36–73) and the most common aetiologies of cirrhosis were hepatitis C (55%), hepatitis B (10%) and alcohol (25%) with 10% other. The median follow-up period was 22 months (12–56) and the median number of scans 4 (2–10). At baseline nodules were described as indeterminate in 48%, regenerative in 45% and dysplastic in 7%. The prevalence of HCC after 1, 2, 3 and 4 years of follow-up was 5 (17%), 9 (31%), 11 (38%) and 11 (38%) respectively, with the highest incidence occurring in the first 2 years of follow-up (82% of cases). The median size of nodule at baseline in those who developed HCC was 10 mm (5–18) and it was 9 mm (5–26) in those who did not. There was no association between the description of the nodule and the likelihood of developing HCC (five arising from indeterminate and 6 from regenerative nodules) and the two nodules initially described as dysplastic did not transform to tumour. AFP results were not informative.Conclusion31% of lesions described as arterialised nodules when first scanned developed into HCC within 2 years and initial radiological features consistent with “regenerative” nodules are not reassuring. Patients with discrete arterialised nodules should be enrolled in enhanced surveillance programmes.Competing interestsNone declared.</description><subject>Epidemiology</subject><subject>Hepatitis</subject><subject>Liver cancer</subject><subject>Liver cirrhosis</subject><subject>Surveillance</subject><issn>0017-5749</issn><issn>1468-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkM1OGzEUha2KSgTKKyBLrE197fmxVxVKSUoFpaKhi24sj-cOTOqMgz2Dyq4bXpQnIWEQa1Zn851zpI-QQ-DHALL4fDP0y84zwUEwyUUOmTsW8IFMICsUk0KpHTLhHEqWl5neJXspLTnnSmmYkPXPxTXjAp7-P34N1HpPI95gh9H27T3SLtSDx0QrdGGF9BbXtg8OvR-8jdTZ6NourOwXurhFGob-hQoNzTZ7D2hjohdXZzQN8R5b723n8BP52Fif8OA198n17HQx_cbOL-dn05NzVom8AJZrq2qFKtdSWwmga92UQlaZzWxdVxp42fCGO4sVlIBaiCLPVV0p2bgNCnKfHI276xjuBky9WYYhdptLI7hUZVboQm-oYqRcDClFbMw6tisbHwxws7VrRrtma9e82jViO8_GYpt6_PfWsvGvKUpZ5ubH76mZ_5n9WnyfXZktDyNfrZbv_XgG5FeQYQ</recordid><startdate>201207</startdate><enddate>201207</enddate><creator>Hogan, B</creator><creator>Trembling, P M</creator><creator>Tanwar, S</creator><creator>Yu, D</creator><creator>O'Beirne, J P</creator><creator>Rosenberg, W M</creator><general>BMJ Publishing Group Ltd and British Society of Gastroenterology</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>201207</creationdate><title>PTU-021 Do all regenerative nodules become hepatocellular carcinoma? The outcome of 4 years MRI surveillance</title><author>Hogan, B ; Trembling, P M ; Tanwar, S ; Yu, D ; O'Beirne, J P ; Rosenberg, W M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b2561-59a8d8e85939a3119d9f723b4a4addb9107f0f0caeb171e9226558db83fcd9f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Epidemiology</topic><topic>Hepatitis</topic><topic>Liver cancer</topic><topic>Liver cirrhosis</topic><topic>Surveillance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hogan, B</creatorcontrib><creatorcontrib>Trembling, P M</creatorcontrib><creatorcontrib>Tanwar, S</creatorcontrib><creatorcontrib>Yu, D</creatorcontrib><creatorcontrib>O'Beirne, J P</creatorcontrib><creatorcontrib>Rosenberg, W M</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hogan, B</au><au>Trembling, P M</au><au>Tanwar, S</au><au>Yu, D</au><au>O'Beirne, J P</au><au>Rosenberg, W M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PTU-021 Do all regenerative nodules become hepatocellular carcinoma? The outcome of 4 years MRI surveillance</atitle><jtitle>Gut</jtitle><addtitle>Gut</addtitle><date>2012-07</date><risdate>2012</risdate><volume>61</volume><issue>Suppl 2</issue><spage>A192</spage><epage>A192</epage><pages>A192-A192</pages><issn>0017-5749</issn><eissn>1468-3288</eissn><abstract>IntroductionThere are few epidemiological data on the longitudinal follow-up of nodular lesions in cirrhotic patients.MethodsThe Royal Free Hospital database was searched for all reports of MRI scans of the liver in which the term “nodule” was used. 630 such scans were identified in 369 individual patients between 1 January 2006 and 1 January 2011. Patients were then excluded if there was &lt;1-year follow-up (45), if hepatocellular carcinoma (HCC) was identified on the initial scan (135), if an alternative diagnosis was made (129) or if no significant arterialised lesion was reported despite previous suspicion on ultrasound scanning (31). Retrospective analysis was, therefore, performed on 29 cirrhotic patients with a diagnosis of regenerative, indeterminate or dysplastic arterialised nodules at baseline and &gt;1 year total follow-up with MRI and alpha-fetoprotein (AFP) surveillance.ResultsThe median age at first scan was 55 years (range 36–73) and the most common aetiologies of cirrhosis were hepatitis C (55%), hepatitis B (10%) and alcohol (25%) with 10% other. The median follow-up period was 22 months (12–56) and the median number of scans 4 (2–10). At baseline nodules were described as indeterminate in 48%, regenerative in 45% and dysplastic in 7%. The prevalence of HCC after 1, 2, 3 and 4 years of follow-up was 5 (17%), 9 (31%), 11 (38%) and 11 (38%) respectively, with the highest incidence occurring in the first 2 years of follow-up (82% of cases). The median size of nodule at baseline in those who developed HCC was 10 mm (5–18) and it was 9 mm (5–26) in those who did not. There was no association between the description of the nodule and the likelihood of developing HCC (five arising from indeterminate and 6 from regenerative nodules) and the two nodules initially described as dysplastic did not transform to tumour. AFP results were not informative.Conclusion31% of lesions described as arterialised nodules when first scanned developed into HCC within 2 years and initial radiological features consistent with “regenerative” nodules are not reassuring. Patients with discrete arterialised nodules should be enrolled in enhanced surveillance programmes.Competing interestsNone declared.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Society of Gastroenterology</pub><doi>10.1136/gutjnl-2012-302514c.21</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0017-5749
ispartof Gut, 2012-07, Vol.61 (Suppl 2), p.A192-A192
issn 0017-5749
1468-3288
language eng
recordid cdi_proquest_journals_2038746969
source BMJ Journals Online Archive; PubMed Central
subjects Epidemiology
Hepatitis
Liver cancer
Liver cirrhosis
Surveillance
title PTU-021 Do all regenerative nodules become hepatocellular carcinoma? The outcome of 4 years MRI surveillance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T14%3A19%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PTU-021%E2%80%85Do%20all%20regenerative%20nodules%20become%20hepatocellular%20carcinoma?%20The%20outcome%20of%204%E2%80%85years%20MRI%20surveillance&rft.jtitle=Gut&rft.au=Hogan,%20B&rft.date=2012-07&rft.volume=61&rft.issue=Suppl%202&rft.spage=A192&rft.epage=A192&rft.pages=A192-A192&rft.issn=0017-5749&rft.eissn=1468-3288&rft_id=info:doi/10.1136/gutjnl-2012-302514c.21&rft_dat=%3Cproquest_cross%3E2038746969%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2038746969&rft_id=info:pmid/&rfr_iscdi=true